Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

Cited by (441)

Items 101–200 of 441

1. Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?
   Simona Caraiola, Laura Voicu, Ciprian Jurcuț, Alina Dima, Cristian Băicuş, Anda Băicuş, Claudia Oana Cobilinschi, Razvan Adrian Ionescu · 2023 · Biomedicines
2. Antiphospholipid syndrome: the need for new international classification criteria
   Georges El Hasbani, Ali T. Taher, Savino Sciascia, Imad W. Uthman · 2021 · Expert Review of Clinical Immunology
3. Impact of the 2023 ACR / EULAR Classification Criteria on START2 Antiphospholipid Registry
   Anna Aiello, Luca Sarti, Gilda Sandri, Daniela Poli, Piera Sivera, Doris Barcellona, Domenico Prisco, Attilia Maria Pizzini, Giuseppe Vercillo, Emilia Antonucci et al. · 2024 · International Journal of Laboratory Hematology
4. Calciphylaxis in uraemic and nonuraemic settings: clinical risk factors and histopathological findings
   Emad I. Ababneh, Mohamed Hassanein, Anas M. Saad · 2021 · Clinical and Experimental Dermatology
5. Management and outcomes of women with antiphospholipid syndrome during pregnancy
   Jacqueline J. Tao, Sanjana Adurty, Debra D’Angelo, Maria Teresa DeSancho · 2023 · Journal of Thrombosis and Thrombolysis
6. Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant
   Chiara Novelli, Paola Pradella, Maria Papandrea, Barbara Montaruli · 2023 · Blood Coagulation & Fibrinolysis
7. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
   Yuan Zhao, Can Liang Huang, Wanting Qi, Yangzhong Zhou, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng · 2023 · RMD Open
8. Lupus Anticoagulant-Hypoprothrombinemia Syndrome and Pseudotumor Cerebri as an Initial Presentation of Systemic Lupus Erythematosus in a 16-Year-Old Male Patient: A Case Report and Literature Review
   Mohamed H. Omer, Hind Salama, Asim M. Alghaythi, Abdullah A. Alharbi, Ghassan Aljohani · 2022 · American Journal of Case Reports
9. Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension
   Rui Zhu, Gang-Yi Cheng, Gentian Denas, Vittorio Pengo · 2023 · European Journal of Internal Medicine
10. Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies
    Katrien M.J. Devreese · 2024 · Seminars in Thrombosis and Hemostasis
11. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines
    Gilberto Pires da Rosa, Ignasi Rodríguez‐Pintó, Ricard Cervera, Gerard Espinosa · 2021 · Expert Review of Hematology
12. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance
    Elena Pontara, Maria Grazia Cattini, Elisa Bison, Chun‐Yan Cheng, Gentian Denas, Vittorio Pengo · 2022 · Thrombosis Research
13. Harmonization of Hemostasis Testing Across a Large Laboratory Network: An Example from Australia
    Emmanuel J. Favaloro, Soma Mohammed, Ronny Vong · 2023 · Methods in molecular biology
14. Lupus Anticoagulant Detection under the Magnifying Glass
    Molinari, Angelo Claudio, Martini, Tiziano, Banov, Laura, Ierardi, Antonella, Leotta, Marzia, Strangio, Alessandra, Santoro, Rita Carlotta · 2023 · Journal of Clinical Medicine
15. Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients
    Mireia Constans, Raquel Santiago, Lidia Jimenez, Cristina Motlló, R. J. F. Lopez, Jaume Trapé, Joan Carles Reverter, Albert Altés · 2021 · Thrombosis Research
16. Current status and role of antiphospholipid antibody testing in cryptogenic stroke
    Wookjin Yang, Min Kyoung Kang, Sue Young Ha, Dong‐Wan Kang, Jeonghoon Bae, Eung‐Joon Lee, Han‐Yeong Jeong, Jeong‐Min Kim, Keun‐Hwa Jung, Seung‐Hoon Lee · 2021 · European Journal of Neurology
17. Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
    Armando Tripodi, Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi · 2023 · Biomedicines
18. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
    Giorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, Margaret Mascherpa, Rossana Orabona, Cristina Zanardini, Sonia Zatti, Silvia Piantoni, Maria Grazia Lazzaroni, Cesare Tomasi et al. · 2022 · Frontiers in Immunology
19. Laboratory and Molecular Diagnosis of Factor XI Deficiency
    Simon J. Davidson, Keith Gomez · 2024 · Seminars in Thrombosis and Hemostasis
20. Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes
    Kimberly A. Moyle, David Ware Branch, Lisa K. Peterson, Marta M. Guerra, Amanda A. Allshouse, Ashley E. Benson, Jane E. Salmon · 2024 · Obstetrics and Gynecology
21. Antiphospholipid antibodies and cardiovascular thrombosis
    Sina Rashedi, Hannah Leyva, Saman Asad Siddiqui, Syed Bukhari, Mariana Becker Pfeferman, Nathan W. Watson, Francisco Ujueta, Mehrdad Zarghami, Bassil Bacare, Yogendra M. Kanthi et al. · 2026 · Nature Reviews Cardiology
22. Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey
    Hae In Bang, Ja Young Lee, Hyun‐Young Kim, Saeam Shin, Myung‐Hyun Nam, In‐Suk Kim, Jimyung Kim, Jonghyun Yoon, Myung‐Geun Shin, Sang Mee Hwang et al. · 2024 · Clinical and Applied Thrombosis/Hemostasis
23. How We Interpret Thrombosis with Thrombocytopenia Syndrome?
    Shinya Yamada, Hidesaku Asakura · 2024 · International Journal of Molecular Sciences
24. Avascular Necrosis of the Femoral Head in Patients with Antiphospholipid Syndrome: A Case Series
    Paschalis Evangelidis, Eleni Gavriilaki, Nikolaos Kotsiou, Zacharo Ntova, Panagiotis Kalmoukos, Theodosia Papadopoulou, Sofia Chissan, Sofia Vakalopoulou · 2025 · Hematology Reports
25. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
    Elena Gkrouzman, Rohan Willis, DANIELI CASTRO OLIVEIRA DE ANDRADE, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza, Michael H Belmont, Paul R. Fortin, Maria Gerosa, Flávio Signorelli et al. · 2023 · Laboratory Investigation
26. Laboratory Testing for Non-criteria Antiphospholipid Antibodies: Anti-phosphatidylserine/Prothrombin Antibodies (aPS/PT)
    Katrien M.J. Devreese · 2023 · Methods in molecular biology
27. Simplified Method for Removing Direct Oral Anticoagulant Interference in Mechanical Coagulation Test Systems—A Proof of Concept
    Thomas Exner, Manita Dangol, Emmanuel J. Favaloro · 2024 · Journal of Clinical Medicine
28. Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS
    Zen, Margherita, Tonello, Marta, Carta, Francesco, Calligaro, Antonia, Favaro, Maria, Del Ross, Teresa, Hulej, Greta, Rahmé, Zahrà, Ruffatti, Amelia, Doria, Andrea · 2025 · Rheumatology
29. Antiphospholipid Syndrome in Renal Allograft Recipients—A Long-Term Multicenter Analysis
    Agnieszka Furmańczyk-Zawiska, Barbara Bułło‐Piontecka, Michał Komorniczak · 2023 · Journal of Clinical Medicine
30. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives
    Thomas Foret, Virginie Dufrost, Jérémy Lagrange · 2024 · Current Rheumatology Reports
31. Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus
    Eleonora Galosi, Carmelo Pirone, Fulvia Ceccarelli, Nicoletta Esposito, Pietro Falco, Martina Leopizzi, Valeria Di Maio, Lorenzo Tramontana, Gianfranco De Stefano, Giuseppe Di Pietro et al. · 2024 · Journal of the Peripheral Nervous System
32. Antiphospholipid antibody positivity is associated with maturation failure and thrombosis of native arteriovenous fistula: a retrospective study in HD patients
    Maxime Taghavi, Lucas Jacobs, Anne Demulder et al. · 2024 · Clinical Kidney Journal
33. Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting
    Luigi Devis, Deepa J. Arachchillage, Michael J Hardy et al. · 2025 · Hämostaseologie
34. Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis
    Elise Schapkaitz, Elena N. Libhaber, Barry Frank Jacobson · 2022 · International Journal of Laboratory Hematology
35. Role of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome: Still matter of debate. Comment on: “Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis”
    Arne Vandevelde, Katrien M.J. Devreese · 2022 · Thrombosis Research
36. Antiphospholipid Syndrome: To Classify or Not to Classify?
    Doruk Erkan · 2024 · Turkish Journal of Hematology
37. Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
    Ariela Hoxha, Nicola Perin, Marco Lovisotto, Antonia Calligaro, Teresa Del Ross, Maria Favarò, Marta Tonello, Andrea Doria, Paolo Simioni · 2024 · Journal of Autoimmunity
38. Direct oral anticoagulants‐Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors
    Danielle White, Gary W. Moore, Martin W. Besser, Stephen G. MacDonald, Will Thomas · 2022 · Research and Practice in Thrombosis and Haemostasis
39. Assessment of 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Spanish cohort
    Rodrigo Cantera Estefanía, Rafael Gálvez Sánchez, María Abando Casuso, José Antonio Flores García, Raquel García Ruiz, Irene Gorostidi Álvarez, Héctor Cruz Barquín, María Oviedo Madrid, Marina Herrero López, Ligia Gabriela Gabrie Rodríguez et al. · 2025 · Clinical Chemistry and Laboratory Medicine (CCLM)
40. Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome
    Óscar Cabrera-Marante, Daniel Enrique Pleguezuelo, Sara Garcinuño, Laura Naranjo, Raquel Díaz‐Simón, Francisco Javier Gil‐Etayo, Denis Zafra, Fernando Lozano-Morillo, Luis Morillas, Magdalena Abad et al. · 2025 · Frontiers in Immunology
41. Genetic Analysis of Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Single-Center Observational Study
    Zsuzsanna Bereczky, Gábor Kolodzey, Sarolta Borsos · 2025 · Genes
42. Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
    Megan R.W. Barber, Ann Elaine Clarke, Corey D. Adams · 2022 · Canadian Medical Association Journal
43. Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy
    Ozlem Apti Sengün, Tülin Ergun, T. Guctekin · 2023 · Microvascular Research
44. Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods
    Rachel Gehlen, Roxanne G. Moesbergen, Cuicui Bai, Philip G. de Groot, A.J. Gerard Jansen, Joost C.M. Meijers, Bas de Laat, Jasper A. Remijn · 2024 · Research and Practice in Thrombosis and Haemostasis
45. An Overview of Laboratory Testing for Antiphospholipid Antibodies
    Emmanuel J. Favaloro, Leonardo Pasalic · 2023 · Methods in molecular biology
46. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels
    Emmanuel J. Favaloro, Soma Mohammed, Ronny Vong, Leonardo Pasalic · 2023 · Methods in molecular biology
47. Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system
    Melanie Bailey, Dermot A. Linden, Hong Guo-Parke, Olivia Earley, Tünde Pető, Daniel Francis McAuley, Clifford C. Taggart, Joseph C. Kidney · 2023 · Frontiers in Medicine
48. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay
    Moore, Gary W., Foxton, Eleanor, Platton, Sean, Yartey, Nada, White, Danielle, MacDonald, Stephen G. · 2023 · Journal of Thrombosis and Haemostasis
49. Comprehensive comparison of global coagulation assays to differentiate lupus anticoagulant from acquired hemophilia A in patients with prolonged APTT
    Yushi Chikasawa, Kagehiro Amano, Keiko Shinozawa, Masato Bingo, Ryui Miyashita, Tomoko Yamaguchi, Ayano Mitsuhashi, Hiroshi Inaba, Takeshi Hagiwara, Ei Kinai · 2023 · International Journal of Hematology
50. Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
    Yuan Zhao, Wanting Qi, Can Liang Huang · 2023 · Rheumatology and Therapy
51. Lupus anticoagulant test persistence over time and its associations with future thrombotic events
    Colling, Meaghan E., Ay, Cihan, Kraemmer, Daniel, Koder, Silvia, Quehenberger, Peter, Pabinger, Ingrid, Posch, Florian, Gebhart, Johanna · 2022 · Blood Advances
52. Analytical dilemmas in lupus anticoagulant detection
    Moore, Gary W. · 2023 · Exploration of Immunology
53. Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing
    Luuk J.J. Scheres, Saskia Middeldorp · 2024 · Hematology
54. Interferences associated with the factor XIa inhibitors asundexian and milvexian in routine and specialized coagulation assays and their removal by activated charcoal-based adsorbents
    Gavin T. Buckley, Maeve P. Crowley, James V. Harte · 2025 · Journal of Thrombosis and Haemostasis
55. Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
    Lama Alfehaid, Nada Alsuhebany, Hussah N Albahlal, Albatoul Alomran, Abdulmajeed M. Alshehri, Mohammed Abdullah Alsheef, Abdulaali R. Almutairi · 2025 · Clinical and Applied Thrombosis/Hemostasis
56. The Antiphospholipid Syndrome in the Pediatric Population
    Elizabeth E. Sloan, Deborah McCurdy · 2022 · Advances in Pediatrics
57. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome
    Efthymiou, Maria, Bertolaccini, Maria Laura, Cohen, Hannah · 2024 · Rheumatology
58. New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests
    Daiki Shimomura, Osamu Kumano, Kaori Ueda, Keisuke Kitano, Nobuo Arai, Masashi Shimada, Mikio Kamioka · 2024 · International Journal of Laboratory Hematology
59. Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective
    Nicola Bizzaro, Alessio Mazzoni, Teresa Carbone, Luigi Cinquanta, Danilo Villalta, Antonella Radice, Giampaola Pesce, Mariangela Manfredi, Maria Giaele Infantino · 2024 · Autoimmunity Reviews
60. Thrombophilia Testing in Venous Thromboembolism
    Kristina Vrotniakaite-Bajerciene, Anne Angelillo‐Scherrer, Lana A. Castellucci · 2025 · Medical Clinics of North America
61. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
    Erivelton de Azevedo Lopes, Gustavo Guimarães Moreira Balbi, Maria G. Tektonidou et al. · 2021 · Revista Brasileira de Reumatologia
62. Apport de la détection des anticorps antiphosphatidylsérine/prothrombine (aPS/PT) dans le diagnostic et la prise en charge du syndrome des antiphospholipides (SAPL)
    A Delarue, Marie‐Agnès Dragon‐Durey, Luc Darnige · 2022 · La Revue de Médecine Interne
63. Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome—Single Centre Observational Study in the United Kingdom
    Hithin Noble, Christina Crossette‐Thambiah, Zain Odho · 2022 · Seminars in Thrombosis and Hemostasis
64. Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome
    Thomas Ballul, Arthur Mageau, Pascale Roland Nicaise · 2023 · Thrombosis Research
65. Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines
    Laurie Talon, Virginie Fourneyron, Stéphanie Senectaire, Maryse Tardieu, Maxence Tillier, Alexandre Trapani, Adeline Trayaud, Aurélie Vaissade, A.-F. Serre Sapin, Aurélien Lebreton et al. · 2023 · Thrombosis Research
66. Real‐world experience of direct oral anticoagulant use in a single pediatric center
    Gianna G. Valenti, Cynthia Shier Sabo, Michelle Hyde, Madhvi Rajpurkar · 2024 · Pediatric Blood & Cancer
67. Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation
    Maksymilian Hanarz, Michał Ząbczyk, Joanna Natorska · 2024 · Journal of Thrombosis and Haemostasis
68. Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?
    Flávio Signorelli, Gustavo Guimarães Moreira Balbi, Eloísa Bonfá, Eduardo Ferreira Borba, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2021 · Lupus
69. Interpretation of clot‐based lupus anticoagulant assays—Normalizing clotting time against different denominators
    Ling, Li‐Qin, Liu, Chao‐Nan, Huang, Xun‐Bei, Liao, Juan, Jia, Jin, Zhou, Jing · 2022 · International Journal of Laboratory Hematology
70. Utility and Interpretation of Coagulation Mixing Studies
    Michael Losos, Jian Chen · 2022 · Journal of Clinical and Translational Pathology
71. Laboratory Testing for Non-criteria Antiphospholipid Antibodies: Antibodies Toward the Domain I of Beta2-Glycoprotein I (aDI)
    Katrien M.J. Devreese · 2023 · Methods in molecular biology
72. Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test
    Moore, Gary W. · 2023 · Methods in Molecular Biology
73. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT)
    Gary W. Moore · 2023 · Methods in molecular biology
74. Are Antiphospholipid Antibodies a Surrogate Risk Factor for Thrombosis in Sepsis?
    Jecko V. Thachil, Emmanuel J. Favaloro, Giuseppe Lippi · 2023 · Seminars in Thrombosis and Hemostasis
75. Removing direct oral factor Xa inhibitor interferences from routine and specialised coagulation assays using a raw activated charcoal product
    Gavin T. Buckley, Ber Murphy, Niamh Fleming, Maeve P. Crowley, James V. Harte · 2023 · Clinica Chimica Acta
76. Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study
    Tommaso Bucci, Paul R. J. Ames, Vittoria Cammisotto, Chiara Cardamone, Antonio Ciampa, Bianca Mangoni, Massimo Triggiani, Roberto Carnevale, Gregory Y.H. Lip, Daniele Pastori et al. · 2023 · Thrombosis Research
77. Do we need more guidance on thrombophilia testing? Challenges and special considerations
    Francesco Marongiu, Maria Filomena Ruberto, Silvia Marongiu, Antonella Mameli, Doris Barcellona · 2024 · Expert Review of Hematology
78. Taipan snake venom time has high sensitivity for lupus anticoagulants in non‐anticoagulated, triple positive antiphospholipid syndrome patients
    Gary W. Moore, Sean Platton, Nada Yartey, Eleanor Foxton, Danielle White, Stephen G. MacDonald · 2024 · International Journal of Laboratory Hematology
79. Chronic prothrombotic tendency in patients with granulomatosis with polyangiitis
    Teresa Iwaniec, Magdalena Celińska‐Löwenhoff, Lech Zaręba · 2021 · Polskie Archiwum Medycyny Wewnętrznej
80. Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!
    Emmanuel J. Favaloro, Leonardo Pasalic · 2022 · Research and Practice in Thrombosis and Haemostasis
81. Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology
    Jecko V. Thachil · 2021 · Seminars in Thrombosis and Hemostasis
82. Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency
    Matsuda, Masato, Hoshiyama, Yoshiki, Ogawa, Kazuei, Emmi, Mari, Terai, Shuji, Moriyama, Masato · 2023 · Research and Practice in Thrombosis and Haemostasis
83. Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis
    Mariana González‐Treviño, Gabriel Figueroa‐Parra, Jeffrey X. Yang et al. · 2024 · Lara D. Veeken
84. Recent advances in point-of-care testing devices for transfusion medicine
    Rijo Rajeev, Paresh Mohanty, Suvro Sankha Datta · 2025 · TrAC Trends in Analytical Chemistry
85. Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’)
    Jonathan Thaler, Michael Parides, DANIELI CASTRO OLIVEIRA DE ANDRADE et al. · 2025 · Annals of the Rheumatic Diseases
86. Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile
    Óscar Cabrera-Marante, Sara Garcinuño, Daniel Enrique Pleguezuelo, Francisco Javier Gil‐Etayo, Iulian Tenica, Edgard Rodríguez de Frías, Denis Zafra, Nerea Castro, Estela Paz‐Artal, Antonio Serrano et al. · 2023 · International Journal of Molecular Sciences
87. Impact of Inherited Thrombophilia in Women with Obstetric Antiphospholipid Syndrome: A Single-Center Study and Literature Review
    Blanca Camacho Sáez, Víctor Manuel Martínez-Taboada, Ana Merino, Alejandra Comins‐Boo, Belén González-Mesones, Sara Del Barrio-Longarela, Leyre Riancho‐Zarrabeitia, Marcos López‐Hoyos, José L. Hernández · 2024 · Biomedicines
88. Key Issues at the Forefront of Diagnosis and Testing for Antiphospholipid Syndrome
    Jesse C. Qiao, Jenique Bailly, Jessica Opie · 2024 · Clinical and Applied Thrombosis/Hemostasis
89. An In‐Depth Analysis and Classification of Placental Causes of Stillbirth: A 10‐Year Retrospective Study of a Regional Stillbirth Registry
    Leïla Caillault, Rémi Béranger, Philippe Loget, Pauline Blanc‐Petitjean, Maëla Le Lous, Gwenaelle Le Bouar, Alain Lescoat, Ronan Garlantézec, Nicolas Belhomme, the Ille et Vilaine stillbirth study group · 2025 · BJOG An International Journal of Obstetrics & Gynaecology
90. Clinical utility of thrombin generation using ST-Genesia® in patients with hereditary and acquired thrombophilia: A cross-sectional study
    Lina Caspary, Joseph R. Shaw, Odile Stalder, Justine Brodard, Anne Angelillo‐Scherrer, Kristina Vrotniakaite-Bajerciene · 2025 · Thrombosis Research
91. Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort
    Adriana Miranda de Magalhães Franco, Lana Sayuri Makita, Virginia C Perrut, Gustavo Guimarães Moreira Balbi, Alexandre Mendonça de Barros, Flávio Mac Cord Medina, Flávio Signorelli · 2022 · Lupus
92. Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update
    Emmanuel J. Favaloro, Robert C. Gosselin, Leonardo Pasalic, Giuseppe Lippi · 2023 · Methods in molecular biology
93. International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies
    Robert C. Gosselin, Gary W. Moore, Geoffrey W. Kershaw · 2023 · Archives of Pathology & Laboratory Medicine
94. Comparison of different algorithms for lupus anticoagulant detection: a single-center experience
    Apipongrat, Dollapak, Lamool, Rattapan, Arnutti, Pasra, Ruangpratheep, Chetana, Chantkran, Wittawat · 2024 · Research and Practice in Thrombosis and Haemostasis
95. Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
    Jana Úlehlová, Barbora Piskláková, Eliška Ivanovová · 2021 · Diagnostics
96. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic
    Rita Selby, Jameel Abdulrehman · 2021 · The Journal of Applied Laboratory Medicine
97. The postpartum uterine ultrasonographic scale in assessment of uterine involution after cesarean section in treated thrombophilia pregnant patients at term
    Cătălina Filip, Roxana Ana Covali, Demetra Gabriela Socolov et al. · 2022 · Journal of Clinical Laboratory Analysis
98. Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
    Suhyeon Woo, Bohyun Kim, Nam Hun Heo, Min‐Sun Kim, Young Ahn Yoon, Young–Jin Choi · 2022 · Clinical and Applied Thrombosis/Hemostasis
99. Antiphospholipid Antibodies Occurrence in Acute SARS-CoV-2 Infection without Overt Thrombosis
    Alina Dima, Daniela Nicoleta Popescu, Ruxandra Moroti, Elisabeta Stoica, Georgiana State, Florentina Negoi, Ioana Berza, Magda Ileana Pârvu · 2023 · Biomedicines
100. Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant
     Masahiro Ieko, Kazumasa Ohmura, Sumiyoshi Naito, Mika Yoshida, Hisaomi Sasaki, Tsuyoshi Sato, Norifumi Sugawara, Nobuhiko Takahashi, Akitada Ichinose · 2023 · Exploration of Immunology